Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
|Articles|May 4, 2012
Drug Shortages Cut in Half in U.S. After New FDA Powers
Advertisement
New U.S. drug shortages have fallen by more than half this year after President Barack Obama gave regulators the power to head off potential scarcities, the head of the Food and Drug Administration said.
There have been 42 new shortages in 2012, compared with 90 at the same time last year, FDA Commissioner Margaret Hamburg said today on the agency’s website. Obama directed the FDA Oct. 31 to gather information earlier from drugmakers about potential shortages to help find alternate sources, increase production or start new manufacturing before patients’ lives are threatened.
Read the full story:
Source: Bloomberg Businessweek
Advertisement
Related to this article
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Speakers at IDWeek 2026 urged shifting global health partnerships from donor-recipient models to shared, locally led ownership as funding contracts.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Extension Studies in TPIP Show Promise in PAH, PH-ILD
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5